| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LISATA THERAPEUTICS, INC. | SVP, Fin/Treas, Chief Actg Off | Common Stock | 32,311 | $63,652 | $1.97 | 09 Jan 2026 | Direct |
| LISATA THERAPEUTICS, INC. | SVP, Fin/Treas, Chief Actg Off | Stock Option (Right to Buy) | 7,000 | 09 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LSTA | LISATA THERAPEUTICS, INC. | 09 Jan 2026 | 6 | -$12,175 | 4 | SVP, Fin/Treas, Chief Actg Off | 13 Jan 2026, 16:08 |
| LSTA | LISATA THERAPEUTICS, INC. | 09 Jan 2025 | 6 | -$16,938 | 4 | SVP, Fin/Treas, Chief Actg Off | 13 Jan 2025, 16:10 |
| LSTA | LISATA THERAPEUTICS, INC. | 01 Oct 2024 | 2 | +$4,685 | 4 | SVP, Fin/Treas, Chief Actg Off | 02 Oct 2024, 17:19 |
| LSTA | LISATA THERAPEUTICS, INC. | 15 Apr 2024 | 0 | $0 | 3 | Senior Vice President, Finance and Treasury and Chief Accounting Officer Exhibit 24.1 - Power of Attorney | 24 Apr 2024, 20:59 |